Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A pharmacokinetic safety study to compare GTN blood plasma levels of MED2002 with existing cardiovascular GTN drugs

Trial Profile

A pharmacokinetic safety study to compare GTN blood plasma levels of MED2002 with existing cardiovascular GTN drugs

Recruiting
Phase of Trial: Phase I

Latest Information Update: 09 Nov 2018

At a glance

  • Drugs Nitroglycerin (Primary) ; Nitroglycerin
  • Indications Erectile dysfunction
  • Focus Pharmacokinetics; Registrational
  • Acronyms FM58
  • Sponsors Futura Medical
  • Most Recent Events

    • 09 Nov 2018 According to a Futura Medical media release, data from this study will be presented at the 9th Annual Fall Scientific Meeting of SMSNA, (Nov 2018).
    • 14 Mar 2018 According to a Futura Medical media release, data are expected within the next month.
    • 13 Mar 2018 Interim results (n=30) presented in a Futura Medical media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top